Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Reboxetine enhances the olanzapine-induced antipsychotic-like effect, cortical dopamine outflow and NMDA receptor-mediated transmission.

Marcus MM, Jardemark K, Malmerfelt A, Björkholm C, Svensson TH.

Neuropsychopharmacology. 2010 Aug;35(9):1952-61. doi: 10.1038/npp.2010.69. Epub 2010 May 12.

2.

Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission.

Marcus MM, Wiker C, Frånberg O, Konradsson-Geuken A, Langlois X, Jardemark K, Svensson TH.

Int J Neuropsychopharmacol. 2010 Aug;13(7):891-903. doi: 10.1017/S1461145709990794. Epub 2009 Oct 19.

PMID:
19835668
3.

Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine.

Björkholm C, Jardemark K, Marcus MM, Malmerfelt A, Nyberg S, Schilström B, Svensson TH.

Eur Neuropsychopharmacol. 2013 Jul;23(7):709-20. doi: 10.1016/j.euroneuro.2012.05.012. Epub 2012 Jun 23.

PMID:
22732518
4.

Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: behavioral, biochemical, and electrophysiological evidence.

Marcus MM, Jardemark K, Malmerfelt A, Gertow J, Konradsson-Geuken A, Svensson TH.

Synapse. 2012 Apr;66(4):277-90. doi: 10.1002/syn.21510. Epub 2011 Dec 13.

PMID:
22121030
5.

Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission.

Jardemark K, Marcus MM, Malmerfelt A, Shahid M, Svensson TH.

Psychopharmacology (Berl). 2012 May;221(1):115-31. doi: 10.1007/s00213-011-2554-3. Epub 2011 Nov 9.

PMID:
22068461
6.
7.

Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence.

Wadenberg ML, Wiker C, Svensson TH.

Int J Neuropsychopharmacol. 2007 Apr;10(2):191-202. Epub 2006 May 17.

PMID:
16707032
8.

Topiramate augments the antipsychotic-like effect and cortical dopamine output of raclopride.

Eltayb A, Wadenberg ML, Schilström B, Svensson TH.

Naunyn Schmiedebergs Arch Pharmacol. 2005 Nov;372(3):195-202. Epub 2005 Nov 12.

PMID:
16284783
9.

Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia.

Frånberg O, Wiker C, Marcus MM, Konradsson A, Jardemark K, Schilström B, Shahid M, Wong EH, Svensson TH.

Psychopharmacology (Berl). 2008 Feb;196(3):417-29. Epub 2007 Oct 17.

PMID:
17940749
11.

Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.

Eltayb A, Wadenberg ML, Svensson TH.

Biol Psychiatry. 2005 Aug 15;58(4):337-43.

PMID:
16102547
12.

Combined alpha2 and D2/3 receptor blockade enhances cortical glutamatergic transmission and reverses cognitive impairment in the rat.

Marcus MM, Jardemark KE, Wadenberg ML, Langlois X, Hertel P, Svensson TH.

Int J Neuropsychopharmacol. 2005 Sep;8(3):315-27. Epub 2005 Apr 28.

PMID:
15857571
13.

Effects of asenapine on prefrontal N-methyl-D-aspartate receptor-mediated transmission: involvement of dopamine D1 receptors.

Jardemark K, Marcus MM, Shahid M, Svensson TH.

Synapse. 2010 Nov;64(11):870-4. doi: 10.1002/syn.20803.

PMID:
20842721
14.

Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.

Björkholm C, Frånberg O, Malmerfelt A, Marcus MM, Konradsson-Geuken Å, Schilström B, Jardemark K, Svensson TH.

Int J Neuropsychopharmacol. 2014 Oct 31;18(3). pii: pyu068. doi: 10.1093/ijnp/pyu068.

16.
17.

Adjunctive galantamine, but not donepezil, enhances the antipsychotic-like effect of raclopride in rats.

Wiker C, Schilström B, Sandbäck C, Wadenberg ML, Svensson TH.

Int J Neuropsychopharmacol. 2008 Sep;11(6):845-50. doi: 10.1017/S1461145708008730. Epub 2008 Apr 14.

PMID:
18405415
18.

Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.

Wadenberg MG, Browning JL, Young KA, Hicks PB.

Pharmacol Biochem Behav. 2001 Mar;68(3):363-70.

PMID:
11325387
19.

Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.

Masana M, Bortolozzi A, Artigas F.

Int J Neuropsychopharmacol. 2011 Feb;14(1):53-68. doi: 10.1017/S1461145710000908. Epub 2010 Aug 12.

PMID:
20701825
20.

5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.

Rollema H, Lu Y, Schmidt AW, Sprouse JS, Zorn SH.

Biol Psychiatry. 2000 Aug 1;48(3):229-37.

PMID:
10924666

Supplemental Content

Support Center